Medical Research Council collaboration gives UK academia access to AstraZeneca compounds
皇冠注册平台

皇冠注册平台

These compounds had stalled in early testing, often because they didn’t prove effective against the original target. But they may still be useful against other diseases. And because the compounds have al阅读y undergone some preliminary development, any new treatments arising from the research could reach patients faster. Fifteen studies are currently underway covering respiratory illness, muscular dystrophies, bone disease and various mental health conditions.